English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduWhen proteins in the brain form deposits consisting of insoluble aggregates, diseases such as Alzheimer’s or Parkinson’s can occur. Now a research team has come a step closer to understanding this process. In Parkinson’s disease the alpha-synuclein (α-synuclein) protein forms…
Tag: Parkinson’s Disease
New study enhances knowledge about widespread diseases
When proteins in the brain form deposits consisting of insoluble aggregates, diseases such as Alzheimer’s or Parkinson’s can occur. Now a research team has come a step closer to understanding this process. In Parkinson’s disease the alpha-synuclein (α-synuclein) protein forms…
Report discusses potential role of coffee in reducing risk of Alzheimer’s and Parkinson’s
Research suggests that a lifelong regular intake of coffee may have protective effect related to cognitive decline and neurodegenerative conditions1-3
Neurorestore: A Swiss initiative aimed at restoring lost neurological function
The Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again
Neurorestore: A Swiss initiative aimed at restoring lost neurological function
The Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again
Brain diseases with molecular diversity
New insights into abnormal proteins in Parkinson’s disease and MSA
New diagnostic techniques and drug may slow and even reverse cognitive decline from aging
BEER-SHEVA, ISRAEL and BERKELEY, CALIFORNIA…DECEMBER 4, 2019 – A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related…
Brain diseases with molecular diversity
New insights into abnormal proteins in Parkinson’s disease and MSA
New diagnostic techniques and drug may slow and even reverse cognitive decline from aging
BEER-SHEVA, ISRAEL and BERKELEY, CALIFORNIA…DECEMBER 4, 2019 – A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related…
Screening tech advances early detection of Parkinson’s disease
Pioneering technology can spot Parkinson’s when there are no obvious symptoms
Beware of swimming if you use deep brain stimulation for Parkinson’s
Case studies show good swimmers lose ability when device is on
Minimally invasive procedure relieves tremors in Parkinson’s patients
CHICAGO – A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson’s disease (PD) tremor, according to a new…
Minimally invasive procedure relieves tremors in Parkinson’s patients
CHICAGO – A procedure that applies pulses of focused ultrasound to the brain is safe and effective for reducing tremors and improving quality of life in people with essential tremor (ET) or Parkinson’s disease (PD) tremor, according to a new…
Accelerating Medicines Partnership launches data knowledge portal for Parkinson’s disease
Shared platform to catalyze research collaboration toward biomarker discovery to advance the development disease therapies
Increased use of antibiotics may predispose to Parkinson’s disease
Higher exposure to commonly used oral antibiotics is linked to an increased risk of Parkinson’s disease according to a recently published study by researchers form the Helsinki University Hospital, Finland. The strongest associations were found for broad spectrum antibiotics and…
Deep learning to analyze neurological problems
Getting to the doctor’s office for a check-up can be challenging for someone with a neurological disorder that impairs their movement, such as a stroke. But what if the patient could just take a video clip of their movements with…
Royal recognition for neuroscience research at the University of Sheffield
The University of Sheffield has been awarded the Queen’s Anniversary Prize for innovation in neuroscience The prize is the highest national honour that recognises outstanding work by UK universities and colleges that demonstrate quality and innovation in their research Sheffield…
Mount Sinai Researchers Uncover New Molecular Drivers of Parkinson’s Disease
New Approach Will Lead to a Better Understanding of Most Cases
Mount Sinai researchers uncover new molecular drivers of Parkinson’s disease
New approach will lead to a better understanding of most cases
MU researchers describe catatonia in Down syndrome
First longitudinal study highlights positive responses to established catatonia therapies
Scientists develop a new method to detect light in the brain
Researchers from Istituto Italiano di Tecnologia, University of Salento, and Harvard Medical School have developed a new light-based method to capture and pinpoint the epicenter of neural activity. The study published on Nature Methods
MU researchers describe catatonia in Down syndrome
First longitudinal study highlights positive responses to established catatonia therapies
Scientists develop a new method to detect light in the brain
Researchers from Istituto Italiano di Tecnologia, University of Salento, and Harvard Medical School have developed a new light-based method to capture and pinpoint the epicenter of neural activity. The study published on Nature Methods
Fecal transplantation to treat patients with Parkinson’s disease: Hope or hype?
Scientists review the evidence for using fecal transplantation and pre- and probiotics in patients with Parkinson’s disease in the Journal of Parkinson’s Disease
Inflammatory bowel disease appears to impact risk of Parkinson’s disease
Patients with inflammatory bowel disease are more likely to get Parkinson’s disease, reports the Journal of Parkinson’s Disease, however, the risk is very small
Parkinson’s Foundation hosts professional education training in Boston
Joint Collaboration with Beth Israel Deaconess Medical Center and Massachusetts General Hospital
Inflammatory bowel disease appears to impact risk of Parkinson’s disease
Patients with inflammatory bowel disease are more likely to get Parkinson’s disease, reports the Journal of Parkinson’s Disease, however, the risk is very small
Parkinson’s Foundation hosts professional education training in Boston
Joint Collaboration with Beth Israel Deaconess Medical Center and Massachusetts General Hospital
Targeting alpha-synuclein in the gut may slow down Parkinson’s disease
Scientists are testing the hypothesis that by targeting the gut with a compound that can inhibit the aggregation of alpha-synuclein
Targeting alpha-synuclein in the gut may slow down Parkinson’s disease
Scientists are testing the hypothesis that by targeting the gut with a compound that can inhibit the aggregation of alpha-synuclein
Researchers develop a new home-based app to better monitor Parkinson’s disease
Frequent daily evaluations at home using the SleepFit app can minimize risk of uncertain recall
Parkinson’s Foundation partners with Parkinson’s UK
Parkinson’s Foundation grants £200,000 to Parkinson’s UK to invest in the Parkinson’s Virtual Biotech
NASA, industry partner for space-based study of potential Alzheimer’s key
An innovative experiment underway on the International Space Station could help researchers make new progress in the fight against aggressive neurodegenerative diseases such as Alzheimer’s and Parkinson’s
Defining a new approach to treating Parkinson’s disease
Scientists from the University of Cologne have contributed to identifying Cav2.3 as a new target for a promising specific therapy
Scientists shed new light on neural processes behind learning and motor behaviours
The discovery that the cerebral cortex can directly control activities of globus pallidus neurons, which are associated with voluntary movement, could improve our understanding of why some symptoms occur in Parkinson’s and other diseases
Researchers develop a new home-based app to better monitor Parkinson’s disease
Frequent daily evaluations at home using the SleepFit app can minimize risk of uncertain recall
NASA, industry partner for space-based study of potential Alzheimer’s key
An innovative experiment underway on the International Space Station could help researchers make new progress in the fight against aggressive neurodegenerative diseases such as Alzheimer’s and Parkinson’s
Defining a new approach to treating Parkinson’s disease
Scientists from the University of Cologne have contributed to identifying Cav2.3 as a new target for a promising specific therapy
Parkinson’s Foundation partners with Parkinson’s UK
Parkinson’s Foundation grants £200,000 to Parkinson’s UK to invest in the Parkinson’s Virtual Biotech
Scientists shed new light on neural processes behind learning and motor behaviours
The discovery that the cerebral cortex can directly control activities of globus pallidus neurons, which are associated with voluntary movement, could improve our understanding of why some symptoms occur in Parkinson’s and other diseases
Better Biosensor Technology Created for Stem Cells
Rutgers innovation may help guide treatment of Alzheimer’s, Parkinson’s diseases
What do we know about the gut microbiota in Parkinson’s disease?
Current research on the gut microbiome and its possible involvement in Parkinson’s disease is promising
Better Biosensor Technology Created for Stem Cells
Rutgers innovation may help guide treatment of Alzheimer’s, Parkinson’s diseases
The pathway to Parkinson’s takes a surprising twist
In neurodegenerative conditions like Parkinson’s disease, a specific group of neurons start to die one by one, causing movement problems and other symptoms. Scientists have long focused on finding out why these neurons die. Now it turns out, they might…
What do we know about the gut microbiota in Parkinson’s disease?
Current research on the gut microbiome and its possible involvement in Parkinson’s disease is promising
The pathway to Parkinson’s takes a surprising twist
In neurodegenerative conditions like Parkinson’s disease, a specific group of neurons start to die one by one, causing movement problems and other symptoms. Scientists have long focused on finding out why these neurons die. Now it turns out, they might…
Researchers report new insights into Parkinson’s disease-related mortality
A Dutch study published in the Journal of Parkinson’s Disease identifies risk factors associated with increased mortality in patients with PD compared to the general population
Where does Parkinson’s disease start? In the brain or gut? Or both?
Scientists writing in the Journal of Parkinson’s Disease hypothesize that Parkinson’s disease can be divided into two subtypes: brain-first, and gut-first
Self-cannibalizing mitochondria may set the stage for ALS development
Powerhouses of the cell ‘eat themselves up,’ jumpstart path to neurodegenerative disease
Sugar-coating proteins can help understand brain disease
A University of Dundee discovery has the potential to help scientists better understand neurological diseases such as Alzheimer’s and Parkinson’s